• Latest Posts

Pharmas step on the gas chasing the next blockbuster in Type 2 Diabetes

French collaboration to develop Oncology-targeted Therapy

A new ‘Fingerprinting’ Identification tool to unlock Algae potential

Novozymes to construct a new R&D campus in Denmark

Apitope’s peptide to take on Haemophilia A

Kurma Partners announces the launch of its third fund Kurma Diagnostics

ADVERTISEMENT

Biosimilars will land in Poland thanks to a European loan

Review: The Emerging Field of Bioluminescence

NuCana’s potent anti-cancer completed Phase I/II

Abivax launched an Euronext IPO to build up its anti-viral portfolio

Novartis declines Gamida’s buyout deal for the second time

ADVERTISEMENT